Sompraz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz hp ## Overview Sompraz hp is a combination medication containing lansoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori*. ## Primary Indications Eradication of *Helicobacter pylori* in patients with peptic ulcer disease. ## Adult Dosing * **Standard Regimen:** Lansoprazole 30 mg, amoxicillin 1000 mg, and clarithromycin 500 mg, all administered orally twice daily for 10-14 days. * **Alternative Regimens:** May vary based on local resistance patterns and prior treatment. Dosing of individual components should be followed as per standard guidelines if components are prescribed separately. ## Pediatric Dosing * Pediatric dosing is not well-established for this specific combination product. Dosing of individual agents may be considered, but requires careful consideration of age, weight, and indication. Lansoprazole dosing in pediatric patients typically ranges from 15-30 mg once daily. Amoxicillin and clarithromycin pediatric dosing is weight-based. Consult specific pediatric guidelines. ## Dose Adjustments * **Renal Impairment:** Dose adjustment for lansoprazole may be considered in severe renal impairment. Amoxicillin and clarithromycin require dose adjustment in renal impairment. * Amoxicillin: Reduce dose or increase interval in severe renal impairment (CrCl < 30 mL/min). * Clarithromycin: Reduce dose or frequency in renal impairment (CrCl < 30 mL/min). * **Hepatic Impairment:** Dose adjustment for lansoprazole may be necessary. Use with caution in moderate to severe hepatic impairment for amoxicillin and clarithromycin. ## Contraindications * Hypersensitivity to lansoprazole, amoxicillin, clarithromycin, or any component of the formulation. * History of severe immediate hypersensitivity reaction to penicillin or cephalosporin antibiotics. * History of cholestatic jaundice/hepatic dysfunction associated with prior macrolide exposure. * Use in patients with severe renal impairment or severe hepatic impairment where dose cannot be adequately adjusted. ## Adverse Effects * **Common:** Diarrhea, nausea, vomiting, abdominal pain, taste disturbance, headache. * **Serious:** *Clostridioides difficile*-associated diarrhea, hypersensitivity reactions (including anaphylaxis), Stevens-Johnson syndrome, toxic epidermal necrolysis, hepatotoxicity, QT prolongation (clarithromycin), *Clostridium difficile* colitis. ## Key Drug Interactions * **Lansoprazole:** Decreased absorption of drugs requiring acidic environment (e.g., ketoconazole, itraconazole, saquinavir). Increased risk of bone fracture with long-term use. * **Amoxicillin:** May decrease the efficacy of oral contraceptives. Probenecid can increase amoxicillin levels. Allopurinol may increase the incidence of rash. * **Clarithromycin:** Significant interactions due to CYP3A4 inhibition. Avoid co-administration with: * Certain statins (e.g., simvastatin, lovastatin) due to increased risk of myopathy. * Certain calcium channel blockers (e.g., verapamil, diltiazem) due to increased risk of hypotension. * Colchicine due to increased risk of toxicity. * Ergot derivatives. * Certain antiarrhythmics (e.g., amiodarone, dronedarone). * Warfarin (monitor INR). * Theophylline (monitor levels). * Do not use with cisapride, pimozide, or domperidone. ## Monitoring * Assess for signs and symptoms of hypersensitivity reactions. * Monitor for development of diarrhea and signs of *Clostridioides difficile*-associated diarrhea. * Monitor renal and hepatic function, especially in patients with pre-existing impairment or those on prolonged therapy. * Monitor INR if co-administered with warfarin. * Monitor for adverse effects specific to clarithromycin (e.g., QT prolongation). * Confirm *H. pylori* eradication with appropriate testing after completion of therapy as per guidelines. ## Clinical Pearls * This combination therapy aims to improve patient adherence and *H. pylori* eradication rates. * Administer as prescribed, usually with meals to minimize GI upset and optimize lansoprazole absorption. * Ensure patients complete the full course of therapy even if they feel better. * Educate patients on potential side effects, particularly diarrhea and the importance of reporting severe or persistent symptoms. * Consider local antibiotic resistance patterns when choosing empiric therapy. *** *Disclaimer: This information is intended for educational purposes only and does not substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines for complete details before making any treatment decisions.*